Economy
Durable Goods Orders
U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.
Durable goods shipments by industry
Durable goods new orders by industry
|
Factory Orders
U.S. Factory orders grew again after dipping in the last month, but Shipments of durable goods fell by -0.73 % to $543 billions.
Factory shipments by industry
Factory new orders by industry
|
Gross Domestic Product
U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.
|
|
Creative Media And Community Trust Corporation
For the fiscal fourth quarter of 2022 Creative Media And Community Trust Corporation Deficit has extended of $-0.39 per share compare to $-0.38 a year before and Income per Share improved from $-0.50 per share from the previous reporting period.
Revenue grew softly by 2.957 % to $25.87 millions from $25.13 millions in the similar reporting period a year before and sequentially Revenues increased by 4.084 % from $24.85 millions.
Creative Media And Community Trust Corporation Customers
Creative Media And Community Trust Corporation Revenue advance Rates
|
![pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Aspira Women S Health Inc
For the fiscal period ending December 31 2022 Aspira Women S Health Inc lost money of $-0.04 per share compare to $-0.08 a year prior and from $-0.04 per share from the previous quarter.
Revenues grew admirably by 16.316 % to $2.15 millions from $1.85 millions in the similar quarter a year prior and sequentially Revenues increased by 3.909 % from $2.07 millions.
Aspira Women S Health Inc Competitors, Market Share
Aspira Women S Health Inc Suppliers
|
|
Recently Reported Results |
Candel Therapeutics Inc
Shifting our attention to the October to December 31 2022 span CADL Diminishing Returns have extended at $-0.15 per share, relative to the earnings of $1.54 per share a year before quarter, In the prior quarter CADL realized $-0.30 per share.
Candel Therapeutics Inc Competitors, Market Share
Candel Therapeutics Inc Revenue improvement Rates
|
Invesco Db G10 Currency Harvest Fund
In the fourth quarter of 2022 financial report Invesco Db G10 Currency Harvest Fund reached balanced books at $0.00 per share, opposite of $0.00 per share a year before reporting season, In the previous reporting season DBV realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund Suppliers
Invesco Db G10 Currency Harvest Fund Income Statement, Balance sheets, Cash Flow Statement
|
|
Galaxy Gaming Inc
For the October to December 31 2022 period Galaxy Gaming Inc realized a shortfall per share of $0.00 in contrast to $0.02 a year before, while Revenues advanced by 4.764 % to $5.94 millions from the same reporting period a year before.
Galaxy Gaming Inc stock quotes, charts, profile
Galaxy Gaming Inc Income Statement, Balance sheets, Cash Flow Statement
|
![pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Calithera Biosciences Inc
The Major Pharmaceutical Preparations industry observers begin to digest the fourth quarter of 2022 numbers. Today they observe operating deficit of $-7.346 millions, from the Calithera Biosciences Inc , which has not cited any revenue yet, for the respective October to December 31 2022 financial reporting period.
Calithera Biosciences Inc Customers
Calithera Biosciences Inc Revenue elevation Rates
|
![oil_Plataform_By_aherrero_(La_Gaviota_Uploaded_by_ecemaml)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/oil/oil_Plataform_By_aherrero_(La_Gaviota_Uploaded_by_ecemaml)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "oil_Plataform_By_aherrero_(La_Gaviota_Uploaded_by_ecemaml)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Vantage Drilling International
An ordinary Revenue advance in the Dec 31 2022 report, by 52.984 % to $76.19 millions supported to cut losses to $-1.33 per share, from $-1.79 in similar the reporting period a year prior.
Vantage Drilling International Suppliers
Vantage Drilling International Income Statement, Balance sheets, Cash Flow Statement
|
![Oil_platform_By_Divulgacao_Petrobras__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/oil/Oil_platform_By_Divulgacao_Petrobras__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Oil_platform_By_Divulgacao_Petrobras__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Surrozen Inc
the Biotechnology & Pharmaceuticals company disclosed $12.5 millions, in Revenue in the fourth quarter of 2022.
Surrozen Inc stock quotes, charts, profile
Surrozen Inc Income Statement, Balance sheets, Cash Flow Statement
|
|
|
|
Recently Reported Results |
Aei Income And Growth Fund Xxi Limited Partnership
For the fiscal time-frame ending December 31 2022 NONE profits turned positive of $0.01 per share compare to $-0.14 a year before and EPS dropped by -99.63 % from $1.64 per share from the prior financial reporting period.
Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the same financial reporting period a year before and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.
Aei Income And Growth Fund Xxi Limited Partnership Customers
Aei Income And Growth Fund Xxi Limited Partnership improvement Rates, Profitability, PE
|
Industrial production
Production by industry
Capacity utilization by industry
|
Better Therapeutics Inc
As the earnings season of the October to December 31 2022 season continues, many businesses have announced the respective earnings. In the thick of it, are several corporations in the Medical Equipment & Supplies sector. As well as, today, Better Therapeutics Inc published operating shortfall of $-8.322 millions, for the October to December 31 2022 time-frame.
Better Therapeutics Inc Customers
Better Therapeutics Inc Suppliers
|
![pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Aptevo Therapeutics Inc
For the fourth quarter of 2022 APVO decreased a loss per share of $-0.84 per share compare to $-1.28 a year before and Income per Share improved from $-1.50 per share from the prior quarter.
Revenues remained unaltered to $0.00 millions from $3.67 millions in the corresponding quarter a year before and sequentially Revenue Tumbled from $0.00 millions.
Aptevo Therapeutics Inc Competitors, Market Share
Aptevo Therapeutics Inc rise Rates, Profitability, PE
|
![Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Candel Therapeutics Inc
Focusing on the most recent fiscal period the Biotechnology & Pharmaceuticals company Diminishing Returns have widen at $-0.15 per share, relative to the recent numbers of $1.54 per share a year prior reporting season, In the prior reporting season the Candel Therapeutics Inc realized $-0.30 per share.
Candel Therapeutics Inc Competitors, Market Share
Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement
|
Producer Price Index
Prices increased on the faster pace again, adding to inflationary worries.
|
![Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/shopping/Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Personal Income and Spending
|
![Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/auto/Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Auto Sales
|
Invesco Db G10 Currency Harvest Fund
In the October to December 31 2022 Invesco Db G10 Currency Harvest Fund reached balanced books at $0.00 per share, opposite of $0.00 per share a year before financial reporting period, In the previous financial reporting period DBV realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile
Invesco Db G10 Currency Harvest Fund Revenue rise Rates
|
![Allure_of_the_SeasBy_Makele-90_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/hotel/Allure_of_the_SeasBy_Makele-90_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Allure_of_the_SeasBy_Makele-90_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Galaxy Gaming Inc
For the most recent fiscal period company realized net loss per share of $0.00 relative to $0.02 a year ago, while Revenues advanced by 4.764 % to $5.94 millions from the similar quarter a year ago.
Galaxy Gaming Inc Competitors, Market Share
Galaxy Gaming Inc Suppliers
|
|
Calithera Biosciences Inc
As the earnings season of the October to December 31 2022 period continues, many corporations have disclosed their results. Among them, have been various constituents of the Major Pharmaceutical Preparations sector. And now, CALA disclosed operating shortfall of $-7.346 millions, for the financial three months ending December 31 2022.
Calithera Biosciences Inc stock quotes, charts, profile
Calithera Biosciences Inc Income Statement, Balance sheets, Cash Flow Statement
|
|
Vantage Drilling International
Energetic Revenue advance in the fiscal three months ending December 31 2022, by 52.984 % to $76.19 millions supported to cut losses to $-1.33 per share, from $-1.79 in same the quarter a year ago.
Vantage Drilling International Suppliers
Vantage Drilling International Income Statement, Balance sheets, Cash Flow Statement
|
|
Surrozen Inc
Surrozen Inc revealed $12.5 millions, in Revenue in the financial period closing December 31 2022.
Surrozen Inc Suppliers
Surrozen Inc Revenue growth Rates
|
![Sikh_wearing_turban_By_Photography_by_Harkanwal_Singh._(Harkanwal_Singh)__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Common](../news/img/communication/Sikh_wearing_turban_By_Photography_by_Harkanwal_Singh._(Harkanwal_Singh)__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Common.jpg "Sikh_wearing_turban_By_Photography_by_Harkanwal_Singh._(Harkanwal_Singh)__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Common")
Ast Spacemobile Inc
Underlining the fourth quarter of 2022 earnings season ASTS reached balanced books at $0.00 per share, relative to the results of $0.32 per share a year ago reporting season, In the preceding reporting season ASTS realized $-0.18 per share.
Ast Spacemobile Inc Competitors, Market Share
Ast Spacemobile Inc Suppliers
|
|
|
|
|
![Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")